Multidomain lifestyle intervention has been studied in 213 papers since 2016: 107 trials and 25 observational studies in people, 54 reviews; 89 in the past year. The newest story, Nov 16, 2026: “Blood proteins linked to cognitive response in lifestyle trial”.
Independent labs found the same change in people. 58 independent labs in 33 countries; 4 trials, 2 about aging.
“Overall, FI-E scores were relatively lower among lifestyle participants throughout follow-up, averaging 0.0130 [95% confidence interval: 0.0104, 0.0156] (p < .001) less across the 18 years.”
Humans: replicated by independent labs. Cells, worms or flies and mice: nothing yet.
C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.
Labs are independent when their papers share no last author and no institution.
Against: findings that point the other way from most findings on the same outcome.
About aging: the drug’s trials about aging. The total counts its trials for every use.
Company ties: findings with an author at a company, or from a paper whose competing-interests statement declares ties to one.
433 peopleBoth65-85 yearsOlder adults; mild cognitive impairment, High DVS group
Clinical nutrition ESPEN, Sep 29, 2026
What did studies of multidomain lifestyle intervention find?
122
Studies of multidomain lifestyle intervention measured 122 outcomes; the most studied are cognitive function (41 studies), frailty (8) and physical function (6).
Cognitive function
↑upin humans38↔no changein humans7
41 studies
Multidomain lifestyle intervention improves cognitive function in humans.
“the change in cognitive performance from baseline to 18 months differed significantly between intervention and control groups, with greater decline observed in the control group.”
Human trialMild cognitive impairment subgroup characterized by elevated GFAP and multiple biomarker abnormalities18 months
Multidomain lifestyle intervention improves cognitive function in humans (0.076 [0.038, -0.114]).
“Both interventions resulted in significant improvements in cognitive test scores, with greater improvements among participants assigned to the Structured intervention.”
The journals of gerontology. Series A, Biological sciences and medical sciences·
Multidomain lifestyle intervention improves cognitive function in humans (mild cognitive impairment) (from 73.94 to 82.32).
“the intervention group showed a significant increase in mean cognitive scores (Addenbrooke’s cognitive examination), rising from 73.94 to 82.32 (p < 0.001)”
Multidomain lifestyle intervention improves cognitive function in older adults with subjective cognitive decline or mild cognitive impairment (adjusted mean difference 0.06 (95% CI -0.00 to 0.13), p=0.055).
“the increment was higher in the intervention compared with the control arm (adjusted mean difference at 24 months: 0.06 [95% Confidence Interval ‐0.00–0.13], p =0.055)”
Human trialin older adults with subjective cognitive decline or mild cognitive impairment24 monthsn = 635
Multidomain lifestyle intervention improves cognitive function in humans (MCI or SCD and 2 or more dementia risk factors) (ES range 0.21 to 0.41).
“We observed significant main effects of time for both primary outcomes and most secondary outcomes, suggesting general improvement over time regardless of treatment group (ES range: 0.21 to 0.41).”
Human trialMCI or SCD and 2 or more dementia risk factors3 to 6 monthsn = 165
“Figure shows that patients who took the supplement and participated in the exercise program exhibited a reduction of −2.5 [−2.9, −2.0] points in frailty according to the SHARE‐FI (Romero‐Ortuno et al. ) and also exhibited a reduction in Fried's frailty criteria of −1.8 [−2.2, −1.5] points (Fried et al”
“The disparity in CHS frailty score reduction between urban (−0.21, 95 % CI: −0.38 - −0.03 p = 0.025) and rural participants (−0.08, 95 % CI: −0.27 – 0.11 p = 0.424) were significant.”
Multidomain lifestyle intervention decreases frailty in men who were pre-frail or frail at baseline (45% vs 30%).
“Among men, those in the intervention group who were pre-frail or frail at the baseline, had a higher probability of being non-frail after 24 months (45%) than pre-frail or frail men in the control group (30%) (p = 0.036).”
Human trialin men who were pre-frail or frail at baselinetwo-year
Multidomain lifestyle intervention decreases frailty in humans (44% vs 30%, p = 0.040).
“Pre-frail or frail men in the intervention group had higher probability of being non-frail after the intervention (44%) than pre-frail or frail men in the control group (30%) (p = 0.040).”
Multidomain lifestyle intervention decreases frailty in humans (type 2 diabetes and either obesity or overweight) (-0.0130 [95% CI: 0.0104, 0.0156], p < .001).
“Overall, FI-E scores were relatively lower among lifestyle participants throughout follow-up, averaging 0.0130 [95% confidence interval: 0.0104, 0.0156] (p < .001) less across the 18 years.”
Human trialtype 2 diabetes and either obesity or overweight18 yearsn = 5,145
The journals of gerontology. Series A, Biological sciences and medical sciences·
All 12Fewer
Physical function
↑upin humans6
6 studies
Multidomain lifestyle intervention improves physical function in humans (p < 0.05).
“positive on most of the cognitive domains, some of the nutrient intake and food groups, physical function, and vascular outcomes (p < 0.05 for all parameters)”
Multidomain lifestyle intervention improves physical function in humans (ηp = 0.253).
“For physical function and functional status, significant intervention effects were observed for the 2-MST (p < 0.001, ηp= 0.253, power = 0.853), 30-CST (p = 0.003, ηp=0.113, power = 0.722), and TUG (p = 0.009, ηp=0.089, power = 0.792) tests (Table 4).”
Multidomain lifestyle intervention improves physical function in humans (p<0.05).
“significant intervention effects were observed for cognition, physical function, body composition, disability, health-related quality of life and self-perceived exercise self-efficacy (p<0.05)”
Multidomain lifestyle intervention improves physical function in LTC facilities.
“Most studies demonstrated improvements in physical functionality (e.g. gait speed, strength and balance), while results regarding quality of life were inconsistent.”
Multidomain lifestyle intervention improves gait speed in humans.
“This was accompanied by a remarkable increase in grip strength, gait speed, and balance (as measured by the Tinetti score) following the multidomain intervention.”
Multidomain lifestyle intervention improves gait speed in humans (participants with low gait speed at baseline) (22 of 30 (73.3%) free of low GS at 6 months).
“Among the components of sarcopenia, GS had the greatest change associated with active interventions, with 22 of 30 participants (73.3%) free of low GS at 6 months”
Human trialparticipants with low gait speed at baseline6 monthsn = 30
APJAET - Journal ay Asia Pacific Journal of Advanced Education and Technology·
Multidomain lifestyle intervention improves physical activity in humans.
“Participants in the intervention group increased physical activity during the first year of the intervention and were physically more active than the control group at the first and the fifth year of the follow-up.”
Multidomain lifestyle intervention increases physical activity in men reporting low level of physical activity at baseline (difference between groups 30 percentage points).
“In the intervention group men reporting low level of physical activity at baseline became more often physically active during the intervention compared with the control group (difference between groups 30 percentage points, p = 0.038).”
Human trialin men reporting low level of physical activity at baselinetwo-year
Multidomain lifestyle intervention decreases body weight in humans (77.0 [68.0–87.0] kg to 75.9 [67.2–85.7] kg).
“For the primary endpoint, there was a significant reduction in weight ( A) from pre-intervention (median [interquartile range]) at 77.0 [68.0–87.0] kg to post-intervention at 75.9 [67.2–85.7] kg (p < 0.0001).”
International journal of environmental research and public health·
Multidomain lifestyle intervention decreases body weight in humans.
“The intervention group exhibited a reduction in body weight and fat mass over the 18-month follow-up period, with a significant difference observed in the change in body weight between the intervention and control groups (P = 0.039) (Table S4, Figure S1).”
Multidomain lifestyle intervention decreases cognitive decline in humans (living at home).
“Multimodal interventions-combining physical activity, cognitive training, a healthy diet and social interaction-represent the most evidence-based approach to slowing cognitive decline in older adults living at home.”
Multidomain lifestyle intervention decreases cognitive decline in humans (at-risk populations).
“combined interventions targeting diet, physical activity, cognitive stimulation, and social activity can slow cognitive decline in at-risk populations.”
Multidomain lifestyle intervention decreases cognitive decline in humans (at increased risk for cognitive decline).
“a structured, multi-domain lifestyle intervention significantly reduces cognitive decline compared to a self-guided approach over the 2 year interventions”
Reviewat increased risk for cognitive decline2 yearn = 2,000
Multidomain lifestyle intervention decreases systolic blood pressure in participants with untreated or uncontrolled VRFs (AMD = −5.11, 95% CI = −9.16 to −1.07).
“Significant differences in changes in systolic blood pressure (adjusted mean difference [AMD] = −5.11, 95% CI = −9.16 to −1.07), pulse pressure (AMD = −4.06, 95% CI = −6.99 to −1.14), HDL‐C (AMD = 2.51, 95% CI = 0.53 to 4.49), TG (AMD = −14.20, 95% CI = −27.30 to −1.17), and TG/HDL‐C (AMD = −0.40, 95% CI = −0.80 to −0.11) were observed between the intervention and control, groups”
Human trialin participants with untreated or uncontrolled VRFs18 monthn = 298
“Intervention participants improved compared to controls in several clinical measures (all P<0.05) including BMI (−1.22 BMI units), waist circumference (−3.02 cm), hip circumference (−2.81 cm), systolic blood pressure (−6.64 mmHg), and percent body fat (−2.32”
Multidomain lifestyle intervention improves depressive symptoms in humans.
“Health-related quality of life and depressiveness were improved in participants with better adherence to nutritional counselling and enhancement of physical and social activities.”
Multidomain lifestyle intervention showed no clear effect on depressive symptoms in humans.
“There was no significant difference in Zung score change between the intervention and control groups (group × time interaction coefficient −0.005, 95% CI −0.018 to 0.007, p = 0.40).”
Multidomain lifestyle intervention showed no clear effect on depressive symptoms in humans (-0.006, 95% CI -0.019 to 0.007).
“Mean Zung score decreased 0.73 (SD 5.6) points in the intervention and 0.36 (5.6) points in the control group, with nonsignificant between-group difference (group × time coefficient -0.006, 95% CI -0.019 to 0.007).”
“Compared to the control group, statistically significant differences (Δ) at 6M for cognitive intervention (Δ=-0.39, p=0.021), physical intervention (Δ =-0.37, p=0.026), and combination intervention (Δ =-0.43, p=0.020), were observed, but not for nutritional intervention.”
Multidomain lifestyle intervention improves grip strength in humans.
“This was accompanied by a remarkable increase in grip strength, gait speed, and balance (as measured by the Tinetti score) following the multidomain intervention.”
Multidomain lifestyle intervention improves grip strength in humans (urban areas vs rural areas).
“Significant results were observed, with grip strength favoring rural areas at the 12 month (p < 0.001), walking speed favoring urban areas at the 12 month (p = 0.002), physical activity favoring urban areas at the six month (4.92, 95 % CI: 0.11 – 9.74, p = 0.090), visuospatial executive function favoring urban areas at the 12 month (p = 0.008), and language function favoring rural areas at the 12 month(p = 0.048”
Human trialurban areas vs rural areas12 monthsn = 1,082
Multidomain lifestyle intervention decreases frailty index in humans (-0.014 (95% CI -0.019, -0.008)).
“Averaged over follow-up, the reductions were −0.014 [95% confidence interval −0.019, −0.008] P <.0001 greater for Structured compared to Self-Guided participants.”
The journals of gerontology. Series A, Biological sciences and medical sciences·
Multidomain lifestyle intervention decreases frailty index in humans (difference averaging -0.014 [-0.019, -0.008] (P < .0001)).
“At 24 months, the mean (standard error) changes from baseline of a 31-component mFI were -0.009 (0.002) for Self-Guided and -0.024 (0.002) for Structured participants, a difference averaging -0.014 [-0.019, -0.008] (P < .0001).”
The journals of gerontology. Series A, Biological sciences and medical sciences·
Multidomain lifestyle intervention decreases frailty index in humans (overweight or obese adults with type 2 diabetes) (mean differences averaged 5.8% and 5.4%, p ≤ .001).
“Random assignment to intensive lifestyle intervention was associated with lower FI scores throughout follow-up as captured by areas under curves traced by longitudinal means (p ≤ .001)”
Human trialoverweight or obese adults with type 2 diabetes8 yearsn = 4,859
Multidomain lifestyle intervention improves HDL cholesterol in participants with untreated or uncontrolled VRFs (AMD = 2.51, 95% CI = 0.53 to 4.49).
“Significant differences in changes in systolic blood pressure (adjusted mean difference [AMD] = −5.11, 95% CI = −9.16 to −1.07), pulse pressure (AMD = −4.06, 95% CI = −6.99 to −1.14), HDL‐C (AMD = 2.51, 95% CI = 0.53 to 4.49), TG (AMD = −14.20, 95% CI = −27.30 to −1.17), and TG/HDL‐C (AMD = −0.40, 95% CI = −0.80 to −0.11) were observed between the intervention and control, groups”
Human trialin participants with untreated or uncontrolled VRFs18 monthn = 298
The journals of gerontology. Series A, Biological sciences and medical sciences·
Multidomain lifestyle intervention decreases cognitive frailty in humans after 24 weeks (63% vs 3.6% reversal of CF at 24 weeks).
“Within the experimental group, 74.1% and 63% of the participants were no longer cognitively frail at the 12th and 24th weeks, respectively, compared to the control group, whereby only 10.7% and 3.6% of the participants exhibited reversal of CF”
Multidomain lifestyle intervention improves health-related quality of life in humans.
“No statistically significant effects were found, except for the two variables (ie, index value and VAS) of HRQOL, showing MIG had an improved HRQOL compared to CG.”
Multidomain lifestyle intervention lowers the risk of cardiovascular disease in humans (history of CVD) (HR 0.50, 95% CI 0.28-0.90).
“incidence of both total CVD events (HR: 0.50, 95% CI: 0.28-0.90) and stroke/TIA (HR: 0.40, 95% CI: 0.20-0.81) was lower in the intervention than the control group”
Multidomain lifestyle intervention lowers the risk of chronic disease in humans (HR 0.80 (95% CI 0.66-0.98) for 1+ new disease; HR 0.38 (0.16-0.88) for 3+ new diseases).
“the intervention group had a hazard ratio ranging from 0.80 (0.66-0.98) for developing 1+ new chronic disease(s) to 0.38 (0.16-0.88) for developing 3+ new chronic diseases compared to the control group”
Human trialadjusted for age, sex, education, current smoking, alcohol intake, and baseline chronic diseases2 yearsn = 1,260
Multidomain lifestyle intervention lowers the risk of pre-frailty/frailty in humans (Compared with regular health advice) (Difference in prevalence change: −9.6 percentage points at 2 years (p = 0.007); −6.2 percentage points at 7 years (p = 0.049)).
“The intervention reduced the risk of pre-frailty/frailty up to 7 years.”
Human trialCompared with regular health advice2-year intervention; benefits through 7 yearsn = 1,259
Multidomain lifestyle intervention lowers the risk of stroke in humans (HR 0.71, 95% CI 0.51–0.99).
“After adjusting for age, education, sex, APOE ɛ4 status, study area, and antihypertensive medication, difference in combined stroke/TIA (HR: 0.71, 95% CI: 0.51–0.99) was larger than in coronary events (HR: 0.84, 95% CI: 0.56–1.26).”
Gut microbiome richness and inverse Simpson diversity
↓downin humans1
1 study
Multidomain lifestyle intervention is associated with gut microbiome richness and inverse Simpson diversity in humans Within-intervention-group change from baseline.
“Observed amplicon sequence variant (ASV) richness and inverse Simpson diversity decreased from baseline to week 24 within the MI group”
Human trialWithin-intervention-group change from baseline24 weeksn = 91
Multidomain lifestyle intervention is associated with trial feasibility in humans (11 Latin American countries) (Reach 62.0%; mean SLI adherence 71.6%).
“A culturally adapted multidomain lifestyle intervention was feasible across Latin America”
Human trial11 Latin American countries2 yearsn = 1,065
Multidomain lifestyle intervention is associated with cingulum cingulate gyrus axial diffusivity in humans.
“the FMI, HMI, and intervention group yielded significantly more beneficial effects on the AD of the CgC.”
Human trialcomparison with controls restricted to regions significant in intervention-group paired t-testsfacility-based and home-basedcingulum cingulate gyrus24 weeks
Multidomain lifestyle intervention lowers the risk of incident persistent frailty in humans (HR 0.53, 95% CI 0.33–0.85).
“decreased risk of developing both frailty (hazard ratio 0.72; 95% confidence interval, 0.55-0.93) and persistent frailty (hazard ratio 0.53; 95% confidence interval, 0.33-0.85)”
Human trialCompared with usual care; adjusted for baseline frailty index; persistent frailty defined at 2 consecutive time points3 yearsn = 1,042
Multidomain lifestyle intervention lowers the risk of incident frailty in humans (Compared with usual care; Cox model adjusted for baseline frailty index) (HR 0.72, 95% CI 0.55–0.93).
“subjects in the multidomain group had a decreased risk of developing both frailty (hazard ratio 0.72; 95% confidence interval, 0.55-0.93)”
Human trialCompared with usual care; Cox model adjusted for baseline frailty index3 yearsn = 1,146
Among 1,158 older adults at risk of dementia, 11 blood proteins were linked to differences in cognitive response to a lifestyle intervention.Among 1,158 older adults at risk of dementia, 11 blood proteins were linked to differences in cognitive response to a lifestyle intervention.
Retention was 100% in both groups in an eight-week randomized trial of 30 people with mild cognitive impairment.Retention was 100% in both groups in an eight-week randomized trial of 30 people with mild cognitive impairment.
A trial analysis in people with mild cognitive impairment identified a blood-marker subgroup with less cognitive decline after lifestyle intervention than in controls…A trial analysis in people with mild cognitive impairment identified a blood-marker subgroup with less cognitive decline after lifestyle intervention than in controls over 18 months.
Who was studied51 people with mild cognitive impairment, 18-month
What changedThinking skills declined less with the lifestyle program than with control care among participants with elevated GFAP and other abnormal biomarkers
The catchThe subgroup was identified and evaluated for intervention benefit within the same cohort
A 24-week trial sub-study followed 130 adults aged 60–79 at risk of dementia and found shifts towards a healthy reference microbial pattern within the intervention group.A 24-week trial sub-study followed 130 adults aged 60–79 at risk of dementia and found shifts towards a healthy reference microbial pattern within the intervention group.